Dunbar, Joi
Morelli, Gaetano
Jain, Rakesh
Vaudreuil, Carrie
Nandy, Indrani
Ona, Victor
Moseley, Margaret K.
Levin, Seth
Kay, Gary
Funding for this research was provided by:
Sage Therapeutics (Sage Therapeutics)
Biogen (Biogen)
Article History
Received: 26 January 2024
Accepted: 10 September 2024
First Online: 20 September 2024
Declarations
:
: This study was performed in accordance with the Declaration of Helsinki and is consistent with Good Clinical Practice guidelines according to the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Harmonized Tripartite Guideline, as well as all applicable regulatory requirements.
: All participants provided written informed consent.
: Joi Dunbar, Carrie Vaudreuil, Indrani Nandy, and Victor Ona are employees of Sage Therapeutics, Inc., and may hold stock and/or stock options. Gaetano Morelli has no conflicts of interest to disclose. Rakesh Jain reports research funding from AbbVie, Lilly, Lundbeck, Otsuka, Pfizer, Shire, and Takeda and participation on advisory boards for Adamas Pharmaceuticals; Alkermes; Corium; Eisai; Janssen; Lilly; Lundbeck; Merck; Neos Therapeutics; Neurocrine Biosciences; Otsuka; Pamlab; Pfizer; Sage Therapeutics, Inc.; Shire; Sunovion; Supernus; Takeda; Teva Pharmaceuticals; and Usona. Rakesh Jain also reports honoraria for speakers’ bureaus from AbbVie, Alkermes, Almatica, Axsome, Corium, Eisai, Intra-Cellular Therapies, Ironshore, Janssen, Lilly, Lundbeck, Merck, Neos Therapeutics, Otsuka, Pamlab, Pfizer, Shire, Sumitomo Pharma, Sunovion, Takeda, Tris Pharma, and Viatris and consulting fees from AbbVie; Acadia; Adamas Pharmaceuticals; Alfasigma; Alkermes; Almatica; Axsome; Biogen Inc.; Boehringer Ingelheim; Cingulate; Corium; Eisai; Evidera; Impel Pharmaceuticals; Janssen; Lilly; Lundbeck; Merck; Neos Therapeutics; Neurocrine Biosciences; Osmotica Pharmaceuticals; Otsuka; Pamlab; Pfizer; Sage Therapeutics, Inc.; Shire; Sumitomo Pharma; Sunovion; Supernus; Takeda; Teva Pharmaceuticals; Transcend Therapeutics; and Viatris. Margaret K. Moseley and Seth Levin are employees of Biogen Inc. and may hold stock. Gary Kay is an employee of Cognitive Research Corporation and may hold stock.